Collegium Appoints Rita Balice-Gordon to its Board of Directors
(WorldNews Business)

STOUGHTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the appointment of Rita Balice-Gordon to its Board of Directors, effective September 24, 2020. `Collegium is honored to welcome Rita to our Board of Directors,` said Mike Heffernan, Founder and Chairman of the Board of Collegium. `Rita`s impressive scientific expertise and industry experience will be incredibly valuable for the Company. We are confident that she will make meaningful contributions to our Board of Directors and that Collegium will benefit from her...